...
首页> 外文期刊>Asian journal of surgery >Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study
【24h】

Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study

机译:在稳定的肾移植受者中改善药物粘附的药物依从性,稳定的肾移植受者:一项潜在的队列研究

获取原文
           

摘要

BackgroundMany immunosuppressive drugs are prescribed as twice-daily dosing. A simplified once-daily dosing of immunosuppressive drug regimen may improve medication adherence. We investigated medication adherence of simplified once-daily immunosuppressive regimen consisting of extended-release tacrolimus, sirolimus, and corticosteroids along with the efficacy and safety of this regimen.MethodsThis study was a prospective, multicenter, controlled and cohort trial. Stable kidney transplant recipients who had received transplantation at least 3 months before the study enrollment were eligible for the study. Participants were required to fill-out the self-reported immunosuppressant therapy barrier scale (ITBS) questionnaire before and after the conversion. Other clinical laboratory parameters and adverse events were evaluated until 6 months post-conversion.ResultsA total of 160 kidney recipients comprised the intention-to-treat population. The mean total ITBS score was 19.5?±?4.0 at pre-conversion and 6 months after converting, the mean total ITBS score was 16.6?±?3.6 (p?
机译:背景技术免疫抑制药物被规定为每日两次给药。一种简化的一次每日免疫抑制药物方案给药可以改善药物依从性。我们调查了由延长释放的Tacrolimus,西罗莫司和皮质类固醇组成的简化一次每日免疫抑制方案的药物依恋以及该方案的疗效和安全性。方法是预期,多中心,控制和队列试验。稳定的肾移植受者至少在学习入学前至少3个月接受移植,符合该研究。参与者需要在转换之前和之后填写自我报告的免疫抑制治疗屏障秤(ITBS)问卷。评估其他临床实验室参数和不良事件,直至转化后6个月。培养160名肾脏受者的总共有160名肾脏受体。平均总ITBS得分为19.5?±4.0在转换前和转换后6个月,平均总ITBS得分为16.6?±3.6(p?<0.001)。特别是,与药物剂量频率有关的4个问题的ITBS评分在预转化后和后转化后显着差异。只有1名患者(0.62%)被诊断为研究期间活组织检查证实的急性排斥反应。转化后平均估计的肾小球过滤速率没有显着变化。总共95名患者(59.4%)具有不良事件,28名患者(17.5%)具有严重的不良事件。没有报道任何接枝损失和1死亡。在转化对曾经每日免疫抑制方案后的依赖性明显改善后,无需额外的功效失败或不良事件的情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号